Detalles de la búsqueda
1.
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases.
J Intern Med
; 293(5): 648-655, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36843323
2.
Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial.
Ann Rheum Dis
; 82(11): 1394-1403, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37607809
3.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Ann Rheum Dis
; 82(1): 3-18, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36357155
4.
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Ann Rheum Dis
; 82(10): 1286-1295, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37423647
5.
Course and predictors of work productivity in gout - results from the NOR-Gout longitudinal 2-year treat-to-target study.
Rheumatology (Oxford)
; 62(12): 3886-3892, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36943375
6.
Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases.
Rheumatology (Oxford)
; 2023 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37773994
7.
Calprotectin, a sensitive marker of inflammation, is robustly assessed in plasma from patients with early or established rheumatoid arthritis by use of different laboratory methods.
Scand J Clin Lab Invest
; 83(5): 330-335, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37343245
8.
Exploring the impact of the national tender system on the use of costly drugs treating rheumatoid arthritis patients in ten rheumatology centers in Norway (2010-2019).
BMC Health Serv Res
; 23(1): 968, 2023 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37679747
9.
Carbon-Footprint Analyses in RCTs - Toward Sustainable Clinical Practice.
N Engl J Med
; 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38749030
10.
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study.
BMC Med
; 20(1): 378, 2022 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36199139
11.
Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial.
J Intern Med
; 292(3): 477-491, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35411981
12.
Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment.
Ann Rheum Dis
; 81(3): 344-350, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34389605
13.
All-cause and cause-specific mortality in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: a nationwide registry study.
Rheumatology (Oxford)
; 61(12): 4656-4666, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35377442
14.
Two-year reduction of dual-energy CT urate depositions during a treat-to-target strategy in gout in the NOR-Gout longitudinal study.
Rheumatology (Oxford)
; 61(SI): SI81-SI85, 2022 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34247224
15.
Using observational study data as an external control group for a clinical trial: an empirical comparison of methods to account for longitudinal missing data.
BMC Med Res Methodol
; 22(1): 152, 2022 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35643430
16.
Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis.
Clin Exp Rheumatol
; 40(7): 1393-1402, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34796837
17.
Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010-2019 - a country with a national tender system for prescription of costly drugs.
BMC Health Serv Res
; 22(1): 48, 2022 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35012522
18.
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial.
JAMA
; 325(17): 1755-1764, 2021 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33944875
19.
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
JAMA
; 326(23): 2375-2384, 2021 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34932077
20.
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
JAMA
; 325(17): 1744-1754, 2021 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33944876